Clinical Trial Update: Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating placebo-controlled augmentation with 5-hydroxytryptophan and creatine in women with treatment-resistant major depressive dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• 5-Hydroxytryptophan (5-HTP)
• Creatine (creatine)

Snippet

Sponsor: Brent Michael Kious, MD, PhD | Conditions: Major Depressive Disorder | Phase 4 | Status: TERMINATED | Results posted: 2022-05-31